TABLE 1.
City, province | Year of initial participation | Current (previous) investigator; associates |
---|---|---|
Vancouver, BC | 1991 | D Scheifele; J Bettinger, project epidemiologist (S Wootton) |
Calgary, AB | 1993 | T Jadavji; J Kellner* |
Edmonton, AB | 1994 | W Vaudry; G Tyrell† |
Saskatoon, SK | 1999 | B Tan |
Winnipeg, MB | 1991 | J Embree (B Law); R Tsang‡ |
Toronto, ON | 1991 | D Tran (R Gold, E Wang, E Ford-Jones) |
Ottawa, ON | 1993 | N Le Saux (N MacDonald); S Whiting§ |
Montreal (MCH), QC | 1993 | D Moore (E Mills) |
Montreal (SJ UHC), QC | 1993 | M Lebel |
Quebec City, QC | 1991 | P Déry; G DeSerres¶ |
Halifax, NS | 1991 | S Halperin |
St John’s, NL | 1993 | R Morris |
Associate member, Pneumococcal surveillance project;
Associate member, Pneumococcal surveillance project (National Centre for Streptococcus);
Associate member, Meningococcal surveillance project (National Microbiology Laboratory);
Associate member, Post-immunization neurologic events;
Associate member, Influenza vaccine effectiveness study, pertussis. AB Alberta; BC British Columbia; MB Manitoba; MCH The Montreal Children’s Hospital; NL Newfoundland and Labrador; NS Nova Scotia; ON Ontario; QC Quebec; SJ UHC Sainte-Justine University Hospital Centre; SK Saskatchewan